Aprogen Pharmaceuticals Inc Capital Reinvestment Ratio
Aprogen Pharmaceuticals Inc capital reinvestment ratio. Aprogen Pharmaceuticals Inc (003060) has a Capital Reinvestment Ratio of 0.87x as of December 2022, meaning it reinvests 1% of its operating cash flow (₩676.93 Million) in capital expenditures (₩591.03 Million). Check 003060 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Aprogen Pharmaceuticals Inc (2010–2022)
Capital reinvestment ratio of Aprogen Pharmaceuticals Inc from 2010 to 2022. This chart tracks Aprogen Pharmaceuticals Inc's Capital Reinvestment Ratio across 7 annual periods. Also explore 003060 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Aprogen Pharmaceuticals Inc Capital Reinvestment Ratio by Year (2010–2022)
Aprogen Pharmaceuticals Inc capital reinvestment ratio by year from 2010 to 2022. For the full cash flow conversion analysis, see 003060 operating cash flow.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.06x | ₩25.73 Billion | ₩1.55 Billion | ▼ -50.2% |
| 2020 | 0.12x | ₩8.09 Billion | ₩976.29 Million | ▼ -96.0% |
| 2019 | 2.98x | ₩713.73 Million | ₩2.13 Billion | ▲ +292.2% |
| 2018 | 0.76x | ₩1.33 Billion | ₩1.01 Billion | ▼ -87.9% |
| 2016 | 6.27x | ₩449.98 Million | ₩2.82 Billion | ▲ +115.6% |
| 2015 | 2.91x | ₩1.85 Billion | ₩5.37 Billion | ▼ -94.1% |
| 2010 | 49.52x | ₩247.92 Million | ₩12.28 Billion | — |